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Since 2008, outbreaks of atypical hand, foot, and 
mouth disease (HFMD) in children and adults have 
been reported worldwide. The majority of these out-
breaks are caused by a new lineage of Coxsackie virus 
A6 (CV-A6) presenting a more severe clinical pheno-
type than the classical childhood HFMD caused by CV-
A16. Between June 2014 and January 2016, 23 cases 
of atypical HFMD disease presented at a Dermatology 
Department at a regional University Hospital in Den-
mark. Patients were referred by general practitioners 
and dermatologists with a variety of clinical diagnoses, 
including eczema herpeticum, vasculitis, syphilis, der-
matophytid, erythema multiforme and Stevens-John-
son syndrome. Three adults and 3 children required 
hospitalization due to extensive skin involvement and 
fever. All reported patients had laboratory-confirmed 
enterovirus infection. This study demonstrated an up-
surge in atypical HFMD caused by CV-A6 in the Region 
of Southern Denmark and that atypical HFMD can be 
difficult to diagnose clinically as it may mimic other 
severe skin diseases. 
Key words: atypical hand, foot, and mouth disease; Coxsackie-
virus A6; diagnostic mimicker.
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Hand, foot, and mouth disease (HFMD) is a common viral illness generally affecting children under 7 
years of age (1). Classical HFMD is a self-limiting con-
dition presenting with oropharyngeal blisters, papular 
vesicles on the palms and soles, and sometimes fever. 
Patients will rarely be referred to the hospital, as symp-
toms are mild and complications, such as encephalitis and 
myocarditis, are rare in Europe (2–4). Seasonal outbreaks 
occur, with incident peaks during the summer and early 
autumn. The major causative agents have been Cox-
sackievirus A16 (CV-A16) and enterovirus (EV)-A71 
within the species EV-A, members of the virus family 
Picornaviridae in the genus Enterovirus (5). 
Since 2008 outbreaks of atypical HFMD caused by 
CV-A6 have been reported worldwide, mostly during the 
winter in temperate climates (6, 7). An increasing number 
of reports indicate that this new lineage of CV-A6 is more 
virulent, causing a widespread vesicular skin eruption 
in children as well as adults (8, 9). In atopic children, a 
clinical presentation resembling eczema herpeticum has 
been described and termed eczema coxsackium (10, 11). 
The histopathological findings are mainly in the epithe-
lium and consist of widespread keratinocyte necrosis and 
spongiosis, often with formation of vesicles. Neutrophilic 
exocytosis and reticular degeneration of the basal cell 
layer also occur. In the papillary dermis there is often 
massive oedema and a variable inflammatory infiltrate 
dominated by lymphocytes. As opposed to common fin-
dings in other viral diseases, there are no multinucleate 
cells, inclusion bodies or koilocytes (12, 13). 
The aim of this study is to present the clinical and pa-
raclinical features of atypical HFMD, in order to inform 
physicians about the new phenotype. Intrafamilial cases 
are also reported. 
METHODS
The Department of Dermatology and Allergy Centre, Odense 
University Hospital see patients referred from primary care phy-
sicians, practicing dermatologists and other hospital departments 
in the Region of Southern Denmark, which covers a population 
of ~1.2 million people. Based on a clinical picture suspicious of 
atypical HFMD, specimens were taken as vesicle fluid swabs, 
oropharyngeal swabs, and/or stool samples. The initial testing for 
EV was performed at the local Department of Microbiology using 
an in-house real-time PCR method. EV-positive samples were 
sent to the National World Health Organization (WHO) Reference 
Center for Polio at Statens Serum Institut for further characteriza-
tion. Here, EV-RNA was subjected to a multiplex 1-step real-time 
assay with semi-nested PCR, and subsequently sequenced using 
Sanger technique targeting the region encoding the VP1 and VP2 
genes, whose sequence corresponds with antigenic serotype (14). 
In addition, all EV-RNA positive samples were routinely cultivated 
in 3 cell lines established as part of the poliovirus surveillance 
programme. For samples that might not have been characterized 
successfully during the first attempts, the typing procedure was 
repeated on cultivated material.
RESULTS
From June 2014 until January 2016, a total of 26 patients 
with a clinical presentation suggesting possible atypical 
HFMD were tested for EV infection. Of these patients, 
23 (88%) tested EV-positive, including 15 adults and 8 
Atypical Hand, Foot, and Mouth Disease Caused by Coxsackievirus 
A6 in Denmark: A Diagnostic Mimicker
Hans-Henrik HORSTEN1, Michael KEMP2, Thea K. FISCHER3, Kim H. LINDAHL4 and Anette BYGUM1
1Department of Dermatology and Allergy Centre, Odense University Hospital, 2Department of Clinical Microbiology, Odense University Hospital, 
University of Southern Denmark, 3Virology Surveillance and Research Section, Department of Microbiological Diagnostics and Virology, 
Statens Serum Institut, Copenhagen, Denmark and University of Southern Denmark, Clinical Institute, and Center for Global Health, and 
4Department of Clinical Pathology, Odense University Hospital, Odense, Denmark
A
ct
aD
V
A
ct
aD
V
A
d
v
a
n
c
e
s 
in
 d
e
rm
a
to
lo
g
y
 a
n
d
 v
e
n
e
re
o
lo
g
y
A
c
ta
 D
e
rm
a
to
-V
e
n
e
re
o
lo
g
ic
a
351Atypical hand, foot, and mouth disease caused by Coxsackievirus A6
Acta Derm Venereol 2018
children. Thirteen patients tested positive for CV-A6, 
while the others could not be subtyped. A total of 3 
adult patients had negative viral testing. Patients were 
referred to the department with the following diagno-
ses: erythema multiforme, Stevens-Johnson syndrome, 
eczema herpeticum, syphilis, dermatophytid, vasculitis, 
psoriasis, impetigo and atopic dermatitis. HFMD was 
suggested as a clinical diagnosis in the referral notes for 
only one patient. Clinical presentations and descriptions 
of adults and children are given in Fig. 1 and Table I. 
All patients were considered immunocompetent. Two 
children (#2, #5) and 2 adults (#12, #19) had a history 
of atopic dermatitis, but none had active dermatitis at 
the initial evaluation. One adult (#13) had a history of 
psoriasis. No other patients had a previous history of 
skin disease. Two adults (#22, #23) had artificial heart 
valves. One child (#1) developed fever and a vesicular 
eruption on the trunk during the last day of a 1-week trip 
to Turkey, while no other patients had a travel history or 
other significant exposures.
Fig. 1. Examples of skin lesions. Erythematous, papulovesicular eruption on the (A) face, (D) back, (B, C) upper and (E, F) lower limbs of an adult, 
and (G, H) trunk and leg of a child. (I) Onychomadesis in a child several weeks after remission of skin eruption.
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The median age of the adult patients was 33 years 
(range 28–67 years), and 80% (12/15) presented with 
fever and oral mucosal symptoms. All adults developed 
a vesicular eruption and presented skin lesions on the 
dorsal and palmar surfaces of the hands; 87% (13/15) 
of adults had facial involvement and 27% (4/15) had 
lesions on the soles with itching and pain. Seven adult 
patients sought emergency care and 3 were hospitalized. 
Of the 8 children included, with a median age of 2 years 
(range 1–8 years), all presented with fever and 75% (6/8) 
presented with skin lesions on the hands and feet. Three 
children were hospitalized with a suspicion of eczema 
herpeticum or impetigo. Among all included patients, 2 
were treated with acyclovir, 4 received systemic antibio-
tics and 2 received systemic corticosteroids. However, 
none of these treatments was effective.
Household transmission was documented in 3 families, 
demonstrating child-to-adult transmission and child-to-
child transmission. In 2 of these families, children were 
only mildly affected compared with their parents, who 
presented with a severe eruption of atypical HFMD. 
Among adults, 47% (7/15) reported recent contact with 
a child who had symptoms compatible with HFMD. 
The first sporadic cases of atypical HFMD in our 
department were seen during summer 2014 and 2015. 
Subsequently most of our patients were clustered bet-
ween September 2015 and January 2016 (Fig. 2). No 
systematic follow-up was performed, but 2 children and 
no adults were reported to have delayed nail shedding.
EV was identified in vesicle fluid samples (12/12), 
oropharyngeal swabs (12/16) and stool samples (11/13). 
In 13 individual cases virus subtyping was performed, 
and all identified CV-A6. In the other patients insufficient 
sample material prevented further subtyping. Details 
and timing of biological samples are listed in Table II.
Skin biopsies were obtained from 1 child and 4 adults. 
In 3 of the biopsies, the dominating features were ke-
ratinocyte necrosis and foci with confluent necrosis 
interpreted as erythema multiforme. There was little 
spongiosis and only sparse intraepithelial inflammation, 
while oedema and lymphocytic inflammation were found 
in the papillary dermis. In one patient the epidermis was 
inconspicuous and the only change was a sparse perivas-
cular infiltrate of lymphocytes. In the biopsy from the 
child, the epithelium did not have keratinocyte necrosis, 
but slight degenerative changes were detected. In the 
papillary dermis, oedema and lymphocytic inflammation 
were seen. The histopathological conclusion was chronic 
inflammatory changes with a possible viral aetiology.
Table I. Clinical presentations and descriptions of 8 children and 15 adults with atypical hand, foot, and mouth disease (HFMD) and 
confirmed enterovirus infection
Pat. 
No.
Age, 
years/
Sex Fever
Oral 
symp-
toms
Involve-
ment of 
hands 
and feet Involvement of other sites
Accompanying 
symptoms
Hospita-
lized Contact with diseased
Skin 
biopsy
1 1/M Yes Yes Yes Face, trunk and extremities No Yes No No
2 1/M Yes Yes Yes Face, trunk and extremities No Yes No Yes
3 1/M Yes Yes Yes Face, trunk and extremities No Yes No No
4 1/F Yes No Yes Face and extremities No No Yes, brother with HFMD No
5 2/M Yes No Yes Face and extremities No No No No
6 4/M Yes Yes Yes Face No No Yes, sister with HFMD No
7 5/F Yes No No ND No No Yes, brother and parents with HFMD No
8 8/M Yes No No Face, trunk and extremities No No Yes, sister and parents with HFMD No
9 21/M Yes Yes Yes Face and buttocks Diarrhoea No No No
10 23/M No Yes Yes Face and scrotum No No No No
11 28/M Yes Yes Yes Face, wrists, trunk, extremities No No No No
12 30/M Yes Yes Yes Face, trunk and extremities Arthralgia No Yes, child with HFMD Yes
13 31/F Yes No Yes Face and distal extremities No No Yes, child with HFMD No
14 32/M Yes Yes Yes Face, trunk and extremities No No Yes, child with HFMD Yes
15 33/F Yes ND Yes ND No No Yes, children and spouse with HFMD No
16 33/F ND ND Yes Face, trunk and extremities ND No ND No
17 34/M Yes Yes Yes Face, trunk and extremities ND Yes Yes, child with HFMD No
18 40/M Yes Yes Yes Wrists and ears Arthralgia, diarrhoea, 
testicular pain
No Yes, child with HFMD Yes
19 40/F ND ND ND Face, trunk and extremities ND No ND No
20 41/M Yes Yes Yes Face, trunk, extremities, scrotum No No Yes, children and spouse with HFMD No
21 51/F No Yes Yes Face, trunk, extremities, genitalia No Yes Yes Yes
22 58/M No No Yes No Arthralgia No No No
23 67/M Yes Yes Yes Face, trunk and extremities Arthralgia Yes No No
ND: not determined.
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Fig. 2. Seasonal outbreak of atypical hand, food and mouth disease 
in 23 Danish patients.
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DISCUSSION
This report describes the first outbreak of atypical HFMD 
caused by CV-A6 in our region of Denmark. A former 
case report of 2 adults with scalp affection was published 
in 2012 (15), and recently a childhood case has also been 
published by our group (11). In recent years CV-A6 has 
emerged as 1 of the major causes of epidemic HFMD 
worldwide. The first reported CV-A6 associated outbreak 
was in Finland in 2008 (6, 16), with subsequent outbreaks 
in Singapore (17), France (18), China (19, 20), US (21), 
Thailand (22), Cuba (23), New Zealand (24) and, most 
recently, the UK in 2014 (25). 
Mostly children have been affected during CV-A6 
outbreaks. In this study, surprisingly we saw more adult 
patients than affected children, and also several cases 
of likely intra-familial transmission. EV is considered 
highly contagious, and this is supported by the widespread 
household transmission of CV-A6. Counselling regarding 
hygiene precautions and information about the risk of 
infection through contact with fluid in vesicles, saliva, and 
prolonged stool shedding should be given to prevent di-
sease transmission. In this study, one patient was positive 
for EV approximately 6  months after onset of symptoms. 
However, subtyping for CV-A6 was not possible. 
All adults had a vesicular eruption involving the palms 
and dorsal hands, which differs from the typical HFMD, 
in which the palms are usually favoured. The acral hand 
and feet eruptions were highly symptomatic and led some 
adult patients to seek medical assistance in emergency 
rooms. The palmar and plantar eruption in 2 adult patients 
led their referring dermatologist to suggest syphilis as a 
tentative diagnosis. Several adult patients also displayed 
facial involvement with widespread vesicles, including 
the forehead. This was in contrast to children, who 
mostly had vesicles in a distinct perioral distribution, in 
accordance with earlier reports (10). Two children aged 
1.5 years presented a distinct clinical picture of eczema 
coxsackium. 
The diagnostic methods for determining the presence 
of EV included vesicle fluid swabs, oropharyngeal swabs 
and stool samples. Oropharyngeal swabs were positive 
from day 1 up to 15 days after the onset of symptoms. 
Stool samples were positive from day 1 to day 180, which 
exceeds the expected period of faecal excretion of up to 
3 months (26, 27).
Skin biopsies were taken from 5 patients due to the 
atypical clinical picture. Only a few published cases of 
atypical HFMD have been accompanied by histopatho-
logy. One of the important differences between classical 
HFMD and atypical HFMD is extensive necrosis of the 
epidermis. The necrotic keratinocytes in CV-A6 asso-
ciated HFMD may mimic Stevens-Johnson syndrome, 
erythema multiforme and toxic epidermal necrolysis in 
the microscope, as was the case in 3 of our 5 biopsies. 
This can be a possible pitfall, especially when the clinical 
picture was atypical and could imitate these disorders. 
A former histopathological study of 3 cases pointed out 
that intraepidermal vesiculation with a predominantly 
neutrophil-rich infiltrate was a characteristic feature, 
as well as a specific involvement of the upper stratum 
spinosum and stratum granulosum, with relative sparing 
of the stratum corneum (13). Two of our biopsies were 
without specific changes, and additional biopsies might 
be necessary in order to demonstrate the typical histologi-
cal changes. It has also been reported that histopathology 
can imitate a severe cutaneous drug reaction (28).
In the presented cases, differential diagnoses to atypi-
cal HFMD were ruled out, based on the clinical features, 
histopathology and PCR for herpes simplex and varicella 
zoster virus.
The limitation of our study is that it is a case series 
from a single dermatological department in a hospital set-
ting. The range of referral diagnoses from dermatologists 
included eczema herpeticum, vasculitis, Stevens-Johnson 
syndrome and syphilis, highlighting the mimicking of a 
broad variety of clinical presentations. It is important 
that clinicians are informed about the atypical presenta-
tion of CV-A6-associated HFMD. A correct diagnosis is 
critical to avoid unnecessary therapy and to provide the 
patient with accurate prognostic expectations and advice 
on precautions to limit spread of the disease.
The authors have no conflicts of interest to declare.
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